Cargando…

Amniotic fluid oxidant–antioxidant status in foetal congenital nervous system anomalies

OBJECTIVE: This study aimed to evaluate the oxidant–antioxidant status of amniotic fluid in pregnant women with foetal congenital malformations of the central nervous system. METHODS: We studied pregnant women with foetal congenital nervous system anomalies at 16–22 weeks’ gestation (n = 36). The co...

Descripción completa

Detalles Bibliográficos
Autores principales: Cim, Numan, Tolunay, Harun Egemen, Karaman, Erbil, Boza, Barıs, Bilici, Mustafa, Çetin, Orkun, Yıldızhan, Recep, Sahin, Hanım Guler
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972242/
https://www.ncbi.nlm.nih.gov/pubmed/29210307
http://dx.doi.org/10.1177/0300060517734443
_version_ 1783326401262256128
author Cim, Numan
Tolunay, Harun Egemen
Karaman, Erbil
Boza, Barıs
Bilici, Mustafa
Çetin, Orkun
Yıldızhan, Recep
Sahin, Hanım Guler
author_facet Cim, Numan
Tolunay, Harun Egemen
Karaman, Erbil
Boza, Barıs
Bilici, Mustafa
Çetin, Orkun
Yıldızhan, Recep
Sahin, Hanım Guler
author_sort Cim, Numan
collection PubMed
description OBJECTIVE: This study aimed to evaluate the oxidant–antioxidant status of amniotic fluid in pregnant women with foetal congenital malformations of the central nervous system. METHODS: We studied pregnant women with foetal congenital nervous system anomalies at 16–22 weeks’ gestation (n = 36). The control group (n = 30) consisted of pregnant women at the same gestational age who underwent amniocentesis, resulting in a normal karyotype. We analysed glutathione, catalase, and malondialdehyde levels in amniotic fluid. Enzyme activation was measured by spectrophotometry. RESULTS: The demographic features of the groups were similar in terms of age, parity, body mass index, and gestational weeks. We detected lower glutathione and catalase levels in the foetal congenital anomaly group than in the control group. We detected higher malondialdehyde levels in the foetal congenital anomaly group than in the control group. CONCLUSION: In the organism, the rate of formation of free radicals and their rate of removal are balanced, and this is called oxidative balance. As long as oxidative stability is achieved, the organism is not affected by free radicals. This fact should be kept in mind to avoid any type of teratogenic agent that could lead to congenital disorders.
format Online
Article
Text
id pubmed-5972242
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-59722422018-05-31 Amniotic fluid oxidant–antioxidant status in foetal congenital nervous system anomalies Cim, Numan Tolunay, Harun Egemen Karaman, Erbil Boza, Barıs Bilici, Mustafa Çetin, Orkun Yıldızhan, Recep Sahin, Hanım Guler J Int Med Res Clinical Reports OBJECTIVE: This study aimed to evaluate the oxidant–antioxidant status of amniotic fluid in pregnant women with foetal congenital malformations of the central nervous system. METHODS: We studied pregnant women with foetal congenital nervous system anomalies at 16–22 weeks’ gestation (n = 36). The control group (n = 30) consisted of pregnant women at the same gestational age who underwent amniocentesis, resulting in a normal karyotype. We analysed glutathione, catalase, and malondialdehyde levels in amniotic fluid. Enzyme activation was measured by spectrophotometry. RESULTS: The demographic features of the groups were similar in terms of age, parity, body mass index, and gestational weeks. We detected lower glutathione and catalase levels in the foetal congenital anomaly group than in the control group. We detected higher malondialdehyde levels in the foetal congenital anomaly group than in the control group. CONCLUSION: In the organism, the rate of formation of free radicals and their rate of removal are balanced, and this is called oxidative balance. As long as oxidative stability is achieved, the organism is not affected by free radicals. This fact should be kept in mind to avoid any type of teratogenic agent that could lead to congenital disorders. SAGE Publications 2017-12-06 2018-03 /pmc/articles/PMC5972242/ /pubmed/29210307 http://dx.doi.org/10.1177/0300060517734443 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Clinical Reports
Cim, Numan
Tolunay, Harun Egemen
Karaman, Erbil
Boza, Barıs
Bilici, Mustafa
Çetin, Orkun
Yıldızhan, Recep
Sahin, Hanım Guler
Amniotic fluid oxidant–antioxidant status in foetal congenital nervous system anomalies
title Amniotic fluid oxidant–antioxidant status in foetal congenital nervous system anomalies
title_full Amniotic fluid oxidant–antioxidant status in foetal congenital nervous system anomalies
title_fullStr Amniotic fluid oxidant–antioxidant status in foetal congenital nervous system anomalies
title_full_unstemmed Amniotic fluid oxidant–antioxidant status in foetal congenital nervous system anomalies
title_short Amniotic fluid oxidant–antioxidant status in foetal congenital nervous system anomalies
title_sort amniotic fluid oxidant–antioxidant status in foetal congenital nervous system anomalies
topic Clinical Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972242/
https://www.ncbi.nlm.nih.gov/pubmed/29210307
http://dx.doi.org/10.1177/0300060517734443
work_keys_str_mv AT cimnuman amnioticfluidoxidantantioxidantstatusinfoetalcongenitalnervoussystemanomalies
AT tolunayharunegemen amnioticfluidoxidantantioxidantstatusinfoetalcongenitalnervoussystemanomalies
AT karamanerbil amnioticfluidoxidantantioxidantstatusinfoetalcongenitalnervoussystemanomalies
AT bozabarıs amnioticfluidoxidantantioxidantstatusinfoetalcongenitalnervoussystemanomalies
AT bilicimustafa amnioticfluidoxidantantioxidantstatusinfoetalcongenitalnervoussystemanomalies
AT cetinorkun amnioticfluidoxidantantioxidantstatusinfoetalcongenitalnervoussystemanomalies
AT yıldızhanrecep amnioticfluidoxidantantioxidantstatusinfoetalcongenitalnervoussystemanomalies
AT sahinhanımguler amnioticfluidoxidantantioxidantstatusinfoetalcongenitalnervoussystemanomalies